Costimulatory Molecules as Biomarkers in Cystic Fibrosis

Completed

Conditions studied: Cystic Fibrosis

In brief

The purpose of this study is to investigate the expression of a certain class of molecules, called costimulatory molecules, in humans with Cystic Fibrosis. Cystic Fibrosis is a genetic disorder which renders the lung susceptible to persistent inflammation which, at times, can worsen, resulting in accelerated decline in lung function and eventually death or transplant. Our goal is to determine if the levels of costimulatory markers can be used to predict exacerbation and subsequent lung function decline in subjects with Cystic Fibrosis.

Key facts

Study ID

NCT01353950

Run by

Oregon Health and Science University

People needed

40

Starts

2011-07-01

Expected to finish

2013-06-01

Last updated by the study team

2017-04-06

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Willingness to participate

You may not qualify if…

• Presence of HIV
• Presence of Lymphoma/Leukemia
• Presence of Lung or other solid organ Transplant
• Pregnancy

Where it is running

• Oregon health and Sciences University — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.